The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Glucosamine and Chondroitin Sulfate Market Research Report 2025

Global Glucosamine and Chondroitin Sulfate Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713200

No of Pages : 117

Ask Your Query

Synopsis
Due to the COVID-19 pandemic, the global Glucosamine and Chondroitin Sulfate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Glucosamine and Chondroitin Sulfate market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Glucosamine and Chondroitin Sulfate landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Food Grade Glucosamine and Chondroitin Sulfate accounting for % of the Glucosamine and Chondroitin Sulfate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Glucosamine and Chondroitin Sulfate include ANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc. In terms of revenue, the global 3 largest players have a % market share of Glucosamine and Chondroitin Sulfate in 2021.

This report focuses on Glucosamine and Chondroitin Sulfate volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Glucosamine and Chondroitin Sulfate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Glucosamine and Chondroitin Sulfate Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Grade and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Grade

  • Food Grade Glucosamine and Chondroitin Sulfate
  • Pharmaceutical Grade Glucosamine and Chondroitin Sulfate

Segment by Application

  • Pharmaceutical
  • Dietary Supplements
  • Cosmetics
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Anxin
  • Wantuming Biological
  • Tsi Group
  • Yantai Dongcheng
  • Focus Chem
  • Ybcc
  • Runxin Biotechnology
  • Isba
  • Huiwen
  • Qjbchina
  • Meitek(Synutra International)
  • Hengjie Bio-Pharmaceuticals
  • Nippon Zoki
  • Ggi
  • Summit Nutritionals
  • Sioux Pharm
  • Ruikangda Biochemical
  • Guanglong Biochem
  • Pacific Rainbow
  • Summit Nutritionals International
Index

1 Glucosamine and Chondroitin Sulfate Market Overview
1.1 Product Overview and Scope of Glucosamine and Chondroitin Sulfate
1.2 Glucosamine and Chondroitin Sulfate Segment by Grade
1.2.1 Global Glucosamine and Chondroitin Sulfate Sales Growth Rate Comparison by Grade (2022-2028)
1.2.2 Food Grade Glucosamine and Chondroitin Sulfate
1.2.3 Pharmaceutical Grade Glucosamine and Chondroitin Sulfate
1.3 Glucosamine and Chondroitin Sulfate Segment by Application
1.3.1 Global Glucosamine and Chondroitin Sulfate Sales Comparison by Application: (2022-2028)
1.3.2 Pharmaceutical
1.3.3 Dietary Supplements
1.3.4 Cosmetics
1.3.5 Others
1.4 Global Glucosamine and Chondroitin Sulfate Market Size Estimates and Forecasts
1.4.1 Global Glucosamine and Chondroitin Sulfate Revenue 2017-2028
1.4.2 Global Glucosamine and Chondroitin Sulfate Sales 2017-2028
1.4.3 Glucosamine and Chondroitin Sulfate Market Size by Region: 2017 Versus 2021 Versus 2028
2 Glucosamine and Chondroitin Sulfate Market Competition by Manufacturers
2.1 Global Glucosamine and Chondroitin Sulfate Sales Market Share by Manufacturers (2017-2022)
2.2 Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Glucosamine and Chondroitin Sulfate Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Glucosamine and Chondroitin Sulfate Manufacturing Sites, Area Served, Product Type
2.5 Glucosamine and Chondroitin Sulfate Market Competitive Situation and Trends
2.5.1 Glucosamine and Chondroitin Sulfate Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glucosamine and Chondroitin Sulfate Players Market Share by Revenue
2.5.3 Global Glucosamine and Chondroitin Sulfate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucosamine and Chondroitin Sulfate Retrospective Market Scenario by Region
3.1 Global Glucosamine and Chondroitin Sulfate Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Glucosamine and Chondroitin Sulfate Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Country
3.3.1 North America Glucosamine and Chondroitin Sulfate Sales by Country
3.3.2 North America Glucosamine and Chondroitin Sulfate Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glucosamine and Chondroitin Sulfate Market Facts & Figures by Country
3.4.1 Europe Glucosamine and Chondroitin Sulfate Sales by Country
3.4.2 Europe Glucosamine and Chondroitin Sulfate Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glucosamine and Chondroitin Sulfate Market Facts & Figures by Region
3.5.1 Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Region
3.5.2 Asia Pacific Glucosamine and Chondroitin Sulfate Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Country
3.6.1 Latin America Glucosamine and Chondroitin Sulfate Sales by Country
3.6.2 Latin America Glucosamine and Chondroitin Sulfate Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Facts & Figures by Country
3.7.1 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country
3.7.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Glucosamine and Chondroitin Sulfate Historic Market Analysis by Grade
4.1 Global Glucosamine and Chondroitin Sulfate Sales Market Share by Grade (2017-2022)
4.2 Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Grade (2017-2022)
4.3 Global Glucosamine and Chondroitin Sulfate Price by Grade (2017-2022)
5 Global Glucosamine and Chondroitin Sulfate Historic Market Analysis by Application
5.1 Global Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2017-2022)
5.2 Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Application (2017-2022)
5.3 Global Glucosamine and Chondroitin Sulfate Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ANXIN
6.1.1 ANXIN Corporation Information
6.1.2 ANXIN Description and Business Overview
6.1.3 ANXIN Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ANXIN Glucosamine and Chondroitin Sulfate Product Portfolio
6.1.5 ANXIN Recent Developments/Updates
6.2 WanTuMing Biological
6.2.1 WanTuMing Biological Corporation Information
6.2.2 WanTuMing Biological Description and Business Overview
6.2.3 WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.2.4 WanTuMing Biological Glucosamine and Chondroitin Sulfate Product Portfolio
6.2.5 WanTuMing Biological Recent Developments/Updates
6.3 TSI Group
6.3.1 TSI Group Corporation Information
6.3.2 TSI Group Description and Business Overview
6.3.3 TSI Group Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.3.4 TSI Group Glucosamine and Chondroitin Sulfate Product Portfolio
6.3.5 TSI Group Recent Developments/Updates
6.4 Yantai Dongcheng
6.4.1 Yantai Dongcheng Corporation Information
6.4.2 Yantai Dongcheng Description and Business Overview
6.4.3 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product Portfolio
6.4.5 Yantai Dongcheng Recent Developments/Updates
6.5 Focus Chem
6.5.1 Focus Chem Corporation Information
6.5.2 Focus Chem Description and Business Overview
6.5.3 Focus Chem Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Focus Chem Glucosamine and Chondroitin Sulfate Product Portfolio
6.5.5 Focus Chem Recent Developments/Updates
6.6 YBCC
6.6.1 YBCC Corporation Information
6.6.2 YBCC Description and Business Overview
6.6.3 YBCC Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.6.4 YBCC Glucosamine and Chondroitin Sulfate Product Portfolio
6.6.5 YBCC Recent Developments/Updates
6.7 Runxin Biotechnology
6.6.1 Runxin Biotechnology Corporation Information
6.6.2 Runxin Biotechnology Description and Business Overview
6.6.3 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product Portfolio
6.7.5 Runxin Biotechnology Recent Developments/Updates
6.8 ISBA
6.8.1 ISBA Corporation Information
6.8.2 ISBA Description and Business Overview
6.8.3 ISBA Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.8.4 ISBA Glucosamine and Chondroitin Sulfate Product Portfolio
6.8.5 ISBA Recent Developments/Updates
6.9 Huiwen
6.9.1 Huiwen Corporation Information
6.9.2 Huiwen Description and Business Overview
6.9.3 Huiwen Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Huiwen Glucosamine and Chondroitin Sulfate Product Portfolio
6.9.5 Huiwen Recent Developments/Updates
6.10 QJBCHINA
6.10.1 QJBCHINA Corporation Information
6.10.2 QJBCHINA Description and Business Overview
6.10.3 QJBCHINA Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.10.4 QJBCHINA Glucosamine and Chondroitin Sulfate Product Portfolio
6.10.5 QJBCHINA Recent Developments/Updates
6.11 Meitek(Synutra International)
6.11.1 Meitek(Synutra International) Corporation Information
6.11.2 Meitek(Synutra International) Glucosamine and Chondroitin Sulfate Description and Business Overview
6.11.3 Meitek(Synutra International) Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Meitek(Synutra International) Glucosamine and Chondroitin Sulfate Product Portfolio
6.11.5 Meitek(Synutra International) Recent Developments/Updates
6.12 Hengjie Bio-Pharmaceuticals
6.12.1 Hengjie Bio-Pharmaceuticals Corporation Information
6.12.2 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Description and Business Overview
6.12.3 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product Portfolio
6.12.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
6.13 Nippon Zoki
6.13.1 Nippon Zoki Corporation Information
6.13.2 Nippon Zoki Glucosamine and Chondroitin Sulfate Description and Business Overview
6.13.3 Nippon Zoki Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Nippon Zoki Glucosamine and Chondroitin Sulfate Product Portfolio
6.13.5 Nippon Zoki Recent Developments/Updates
6.14 GGI
6.14.1 GGI Corporation Information
6.14.2 GGI Glucosamine and Chondroitin Sulfate Description and Business Overview
6.14.3 GGI Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.14.4 GGI Glucosamine and Chondroitin Sulfate Product Portfolio
6.14.5 GGI Recent Developments/Updates
6.15 Summit Nutritionals
6.15.1 Summit Nutritionals Corporation Information
6.15.2 Summit Nutritionals Glucosamine and Chondroitin Sulfate Description and Business Overview
6.15.3 Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Summit Nutritionals Glucosamine and Chondroitin Sulfate Product Portfolio
6.15.5 Summit Nutritionals Recent Developments/Updates
6.16 Sioux Pharm
6.16.1 Sioux Pharm Corporation Information
6.16.2 Sioux Pharm Glucosamine and Chondroitin Sulfate Description and Business Overview
6.16.3 Sioux Pharm Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sioux Pharm Glucosamine and Chondroitin Sulfate Product Portfolio
6.16.5 Sioux Pharm Recent Developments/Updates
6.17 Ruikangda Biochemical
6.17.1 Ruikangda Biochemical Corporation Information
6.17.2 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Description and Business Overview
6.17.3 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product Portfolio
6.17.5 Ruikangda Biochemical Recent Developments/Updates
6.18 Guanglong Biochem
6.18.1 Guanglong Biochem Corporation Information
6.18.2 Guanglong Biochem Glucosamine and Chondroitin Sulfate Description and Business Overview
6.18.3 Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Guanglong Biochem Glucosamine and Chondroitin Sulfate Product Portfolio
6.18.5 Guanglong Biochem Recent Developments/Updates
6.19 Pacific Rainbow
6.19.1 Pacific Rainbow Corporation Information
6.19.2 Pacific Rainbow Glucosamine and Chondroitin Sulfate Description and Business Overview
6.19.3 Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Pacific Rainbow Glucosamine and Chondroitin Sulfate Product Portfolio
6.19.5 Pacific Rainbow Recent Developments/Updates
6.20 Summit Nutritionals International
6.20.1 Summit Nutritionals International Corporation Information
6.20.2 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Description and Business Overview
6.20.3 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product Portfolio
6.20.5 Summit Nutritionals International Recent Developments/Updates
7 Glucosamine and Chondroitin Sulfate Manufacturing Cost Analysis
7.1 Glucosamine and Chondroitin Sulfate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glucosamine and Chondroitin Sulfate
7.4 Glucosamine and Chondroitin Sulfate Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glucosamine and Chondroitin Sulfate Distributors List
8.3 Glucosamine and Chondroitin Sulfate Customers
9 Glucosamine and Chondroitin Sulfate Market Dynamics
9.1 Glucosamine and Chondroitin Sulfate Industry Trends
9.2 Glucosamine and Chondroitin Sulfate Market Drivers
9.3 Glucosamine and Chondroitin Sulfate Market Challenges
9.4 Glucosamine and Chondroitin Sulfate Market Restraints
10 Global Market Forecast
10.1 Glucosamine and Chondroitin Sulfate Market Estimates and Projections by Grade
10.1.1 Global Forecasted Sales of Glucosamine and Chondroitin Sulfate by Grade (2023-2028)
10.1.2 Global Forecasted Revenue of Glucosamine and Chondroitin Sulfate by Grade (2023-2028)
10.2 Glucosamine and Chondroitin Sulfate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glucosamine and Chondroitin Sulfate by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Glucosamine and Chondroitin Sulfate by Application (2023-2028)
10.3 Glucosamine and Chondroitin Sulfate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glucosamine and Chondroitin Sulfate by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Glucosamine and Chondroitin Sulfate by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Glucosamine and Chondroitin Sulfate Sales Growth Rate Comparison by Grade (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Glucosamine and Chondroitin Sulfate Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Glucosamine and Chondroitin Sulfate Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Glucosamine and Chondroitin Sulfate Market Competitive Situation by Manufacturers in 2021
Table 5. Global Glucosamine and Chondroitin Sulfate Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Glucosamine and Chondroitin Sulfate Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Glucosamine and Chondroitin Sulfate Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Glucosamine and Chondroitin Sulfate Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Glucosamine and Chondroitin Sulfate Manufacturing Sites and Area Served
Table 11. Manufacturers Glucosamine and Chondroitin Sulfate Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Glucosamine and Chondroitin Sulfate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucosamine and Chondroitin Sulfate as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Glucosamine and Chondroitin Sulfate Sales by Region (2017-2022) & (K Units)
Table 16. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2017-2022)
Table 17. Global Glucosamine and Chondroitin Sulfate Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Region (2017-2022)
Table 19. North America Glucosamine and Chondroitin Sulfate Sales by Country (2017-2022) & (K Units)
Table 20. North America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2017-2022)
Table 21. North America Glucosamine and Chondroitin Sulfate Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2017-2022)
Table 23. Europe Glucosamine and Chondroitin Sulfate Sales by Country (2017-2022) & (K Units)
Table 24. Europe Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2017-2022)
Table 25. Europe Glucosamine and Chondroitin Sulfate Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Glucosamine and Chondroitin Sulfate Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Glucosamine and Chondroitin Sulfate Revenue Market Share by Region (2017-2022)
Table 31. Latin America Glucosamine and Chondroitin Sulfate Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2017-2022)
Table 33. Latin America Glucosamine and Chondroitin Sulfate Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2017-2022)
Table 39. Global Glucosamine and Chondroitin Sulfate Sales by Grade (2017-2022) & (K Units)
Table 40. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Grade (2017-2022)
Table 41. Global Glucosamine and Chondroitin Sulfate Revenue by Grade (2017-2022) & (US$ Million)
Table 42. Global Glucosamine and Chondroitin Sulfate Revenue Share by Grade (2017-2022)
Table 43. Global Glucosamine and Chondroitin Sulfate Price by Grade (2017-2022) & (USD/Unit)
Table 44. Global Glucosamine and Chondroitin Sulfate Sales (K Units) by Application (2017-2022)
Table 45. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2017-2022)
Table 46. Global Glucosamine and Chondroitin Sulfate Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Glucosamine and Chondroitin Sulfate Revenue Share by Application (2017-2022)
Table 48. Global Glucosamine and Chondroitin Sulfate Price by Application (2017-2022) & (USD/Unit)
Table 49. ANXIN Corporation Information
Table 50. ANXIN Description and Business Overview
Table 51. ANXIN Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. ANXIN Glucosamine and Chondroitin Sulfate Product
Table 53. ANXIN Recent Developments/Updates
Table 54. WanTuMing Biological Corporation Information
Table 55. WanTuMing Biological Description and Business Overview
Table 56. WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. WanTuMing Biological Glucosamine and Chondroitin Sulfate Product
Table 58. WanTuMing Biological Recent Developments/Updates
Table 59. TSI Group Corporation Information
Table 60. TSI Group Description and Business Overview
Table 61. TSI Group Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. TSI Group Glucosamine and Chondroitin Sulfate Product
Table 63. TSI Group Recent Developments/Updates
Table 64. Yantai Dongcheng Corporation Information
Table 65. Yantai Dongcheng Description and Business Overview
Table 66. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product
Table 68. Yantai Dongcheng Recent Developments/Updates
Table 69. Focus Chem Corporation Information
Table 70. Focus Chem Description and Business Overview
Table 71. Focus Chem Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Focus Chem Glucosamine and Chondroitin Sulfate Product
Table 73. Focus Chem Recent Developments/Updates
Table 74. YBCC Corporation Information
Table 75. YBCC Description and Business Overview
Table 76. YBCC Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. YBCC Glucosamine and Chondroitin Sulfate Product
Table 78. YBCC Recent Developments/Updates
Table 79. Runxin Biotechnology Corporation Information
Table 80. Runxin Biotechnology Description and Business Overview
Table 81. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product
Table 83. Runxin Biotechnology Recent Developments/Updates
Table 84. ISBA Corporation Information
Table 85. ISBA Description and Business Overview
Table 86. ISBA Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. ISBA Glucosamine and Chondroitin Sulfate Product
Table 88. ISBA Recent Developments/Updates
Table 89. Huiwen Corporation Information
Table 90. Huiwen Description and Business Overview
Table 91. Huiwen Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Huiwen Glucosamine and Chondroitin Sulfate Product
Table 93. Huiwen Recent Developments/Updates
Table 94. QJBCHINA Corporation Information
Table 95. QJBCHINA Description and Business Overview
Table 96. QJBCHINA Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. QJBCHINA Glucosamine and Chondroitin Sulfate Product
Table 98. QJBCHINA Recent Developments/Updates
Table 99. Meitek(Synutra International) Corporation Information
Table 100. Meitek(Synutra International) Description and Business Overview
Table 101. Meitek(Synutra International) Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Meitek(Synutra International) Glucosamine and Chondroitin Sulfate Product
Table 103. Meitek(Synutra International) Recent Developments/Updates
Table 104. Hengjie Bio-Pharmaceuticals Corporation Information
Table 105. Hengjie Bio-Pharmaceuticals Description and Business Overview
Table 106. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product
Table 108. Hengjie Bio-Pharmaceuticals Recent Developments/Updates
Table 109. Nippon Zoki Corporation Information
Table 110. Nippon Zoki Description and Business Overview
Table 111. Nippon Zoki Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Nippon Zoki Glucosamine and Chondroitin Sulfate Product
Table 113. Nippon Zoki Recent Developments/Updates
Table 114. GGI Corporation Information
Table 115. GGI Description and Business Overview
Table 116. GGI Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. GGI Glucosamine and Chondroitin Sulfate Product
Table 118. GGI Recent Developments/Updates
Table 119. Summit Nutritionals Corporation Information
Table 120. Summit Nutritionals Description and Business Overview
Table 121. Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Summit Nutritionals Glucosamine and Chondroitin Sulfate Product
Table 123. Summit Nutritionals Recent Developments/Updates
Table 124. Sioux Pharm Corporation Information
Table 125. Sioux Pharm Description and Business Overview
Table 126. Sioux Pharm Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Sioux Pharm Glucosamine and Chondroitin Sulfate Product
Table 128. Sioux Pharm Recent Developments/Updates
Table 129. Ruikangda Biochemical Corporation Information
Table 130. Ruikangda Biochemical Description and Business Overview
Table 131. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product
Table 133. Ruikangda Biochemical Recent Developments/Updates
Table 134. Guanglong Biochem Corporation Information
Table 135. Guanglong Biochem Description and Business Overview
Table 136. Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Guanglong Biochem Glucosamine and Chondroitin Sulfate Product
Table 138. Guanglong Biochem Recent Developments/Updates
Table 139. Pacific Rainbow Corporation Information
Table 140. Pacific Rainbow Description and Business Overview
Table 141. Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Pacific Rainbow Glucosamine and Chondroitin Sulfate Product
Table 143. Pacific Rainbow Recent Developments/Updates
Table 144. Summit Nutritionals International Corporation Information
Table 145. Summit Nutritionals International Description and Business Overview
Table 146. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product
Table 148. Summit Nutritionals International Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Glucosamine and Chondroitin Sulfate Distributors List
Table 152. Glucosamine and Chondroitin Sulfate Customers List
Table 153. Glucosamine and Chondroitin Sulfate Market Trends
Table 154. Glucosamine and Chondroitin Sulfate Market Drivers
Table 155. Glucosamine and Chondroitin Sulfate Market Challenges
Table 156. Glucosamine and Chondroitin Sulfate Market Restraints
Table 157. Global Glucosamine and Chondroitin Sulfate Sales Forecast by Grade (2023-2028) & (K Units)
Table 158. Global Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Grade (2023-2028)
Table 159. Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Grade (2023-2028) & (US$ Million)
Table 160. Global Glucosamine and Chondroitin Sulfate Revenue Market Share Forecast by Grade (2023-2028)
Table 161. Global Glucosamine and Chondroitin Sulfate Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Glucosamine and Chondroitin Sulfate Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Glucosamine and Chondroitin Sulfate Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Glucosamine and Chondroitin Sulfate Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glucosamine and Chondroitin Sulfate
Figure 2. Global Glucosamine and Chondroitin Sulfate Market Share by Grade in 2021 & 2028
Figure 3. Food Grade Glucosamine and Chondroitin Sulfate Product Picture
Figure 4. Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Product Picture
Figure 5. Global Glucosamine and Chondroitin Sulfate Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical
Figure 7. Dietary Supplements
Figure 8. Cosmetics
Figure 9. Others
Figure 10. Global Glucosamine and Chondroitin Sulfate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Glucosamine and Chondroitin Sulfate Market Size (2017-2028) & (US$ Million)
Figure 12. Global Glucosamine and Chondroitin Sulfate Sales (2017-2028) & (K Units)
Figure 13. Glucosamine and Chondroitin Sulfate Sales Share by Manufacturers in 2021
Figure 14. Global Glucosamine and Chondroitin Sulfate Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Glucosamine and Chondroitin Sulfate Players: Market Share by Revenue in 2021
Figure 16. Glucosamine and Chondroitin Sulfate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2017-2022)
Figure 18. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region in 2021
Figure 19. Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Region (2017-2022)
Figure 20. Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Region in 2021
Figure 21. U.S. Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. U.A.E Glucosamine and Chondroitin Sulfate Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Glucosamine and Chondroitin Sulfate by Grade (2017-2022)
Figure 46. Manufacturing Cost Structure of Glucosamine and Chondroitin Sulfate
Figure 47. Manufacturing Process Analysis of Glucosamine and Chondroitin Sulfate
Figure 48. Glucosamine and Chondroitin Sulfate Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock